Plant breeding plays a vital role in ensuring global food security by increasing crop yields, improving nutritional quality ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

In The State of CRISPR and Genome Editing virtual summit, GEN brings together an outstanding line-up of pioneers and ...

The agreement allows EditCo to integrate Promega's HiBiT, HaloTag, and NanoLuc protein tagging tech with its knock-in gene ...

Chinese biotech HuidaGene reports early success with first CRISPR brain treatment in 9-year-old with MECP2 duplication ...

An expert panel will discuss the latest research on CRISPR and how to use it in biotechnology and disease research.

Researchers have developed a CRISPR technique that allows gene editing in trees like poplar without integrating foreign DNA, overcoming regulatory hurdles. This method uses transient transformation, ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $39.11, marking a +1.48% move from the previous day. Gene therapy developer CRISPR Therapeutics AG (CRSP) is navigating some ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...